State Street’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $291K | Sell |
200,513
-616,735
| -75% | -$894K | ﹤0.01% | 3737 |
|
|
2025
Q1 | $1.13M | Buy |
817,248
+16,300
| +2% | +$22.5K | ﹤0.01% | 3401 |
|
|
2024
Q4 | $2.43M | Buy |
800,948
+44,449
| +6% | +$135K | ﹤0.01% | 3252 |
|
|
2024
Q3 | $3.77M | Buy |
756,499
+148,414
| +24% | +$739K | ﹤0.01% | 3090 |
|
|
2024
Q2 | $3.56M | Buy |
608,085
+473,085
| +350% | +$2.77M | ﹤0.01% | 3077 |
|
|
2024
Q1 | $1.07M | Buy |
135,000
+73,900
| +121% | +$587K | ﹤0.01% | 3453 |
|
|
2023
Q4 | $356K | Buy |
61,100
+19,400
| +47% | +$113K | ﹤0.01% | 3726 |
|
|
2023
Q3 | $107K | Buy |
41,700
+3,200
| +8% | +$8.19K | ﹤0.01% | 4105 |
|
|
2023
Q2 | $96.3K | Buy |
38,500
+14,500
| +60% | +$36.3K | ﹤0.01% | 4254 |
|
|
2023
Q1 | $50.4K | Buy |
24,000
+10,600
| +79% | +$22.3K | ﹤0.01% | 4500 |
|
|
2022
Q4 | $21.8K | Hold |
13,400
| – | – | ﹤0.01% | 4718 |
|
|
2022
Q3 | $41K | Hold |
13,400
| – | – | ﹤0.01% | 4698 |
|
|
2022
Q2 | $42K | Buy |
13,400
+800
| +6% | +$2.51K | ﹤0.01% | 4754 |
|
|
2022
Q1 | $35K | Buy |
12,600
+400
| +3% | +$1.11K | ﹤0.01% | 4849 |
|
|
2021
Q4 | $55K | Hold |
12,200
| – | – | ﹤0.01% | 4688 |
|
|
2021
Q3 | $102K | Buy |
+12,200
| New | +$102K | ﹤0.01% | 4541 |
|